Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis

Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis

Saved in:

Bibliographic Details
Main Authors:	Wanqian Yu, Fan Luo, Jingan Rao, Guangtao Lei, Qinghua Wu, Wen Shen, Pingping Yang, Ping Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	finerenone heart failure HFrEF HFmrEF HFpEF adverse effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1652440/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EVOLUTION‐HF DEallEF: A non‐interventional study of patients with heart failure initiated on dapagliflozin: study design
by: Matthias Paul, et al.
Published: (2025-08-01)

Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis
by: Danilo Menichelli, et al.
Published: (2025-06-01)

The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01)

Zastosowanie empagliflozyny w leczeniu niewydolności serca z łagodnie obniżoną frakcją wyrzutową lewej komory (HFmrEF) u 40-letniego mężczyzny
by: Agnieszka Karolina Major, et al.
Published: (2025-03-01)

Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment
by: Era Gorica, et al.
Published: (2025-07-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-09-01)

Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
by: Sher May Ng, et al.
Published: (2025-10-01)

Multiparity induces persistent myocardial structural, functional and transcriptomic remodelling in mice
by: Ruth R. Magaye, et al.
Published: (2025-07-01)

Chronotropic Incompetence and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
by: Ting‐Tse Lin, et al.
Published: (2025-07-01)

Limited Ventilatory Reserve During Exercise in Heart Failure with Preserved Ejection FractionTake-Home Points
by: Gizem Cifci, MD, et al.
Published: (2025-09-01)

Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway
by: Xinyu Hu, et al.
Published: (2025-08-01)

Prognostic differences between persistent HFrEF and HFrecEF following acute myocardial infarction
by: Jeong Yoon Jang, et al.
Published: (2025-07-01)

Beating Heart Coronary Artery Bypass Grafting with Preemptive Impella<sup>™</sup> 5.5 Assist Device in Ischemic Cardiomyopathy
by: Francesco Cabrucci, et al.
Published: (2025-05-01)

Discrepancy between clinical guidelines and real-world management of heart failure with reduced ejection fraction at University Medical Center Ho Chi Minh City, Vietnam
by: Hoang Vu Vu, et al.
Published: (2025-07-01)

Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
by: Ahmet Celik, et al.
Published: (2025-08-01)

Editorial Foreword
by: ojsadmin production
Published: (2025-07-01)

Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study
by: Arif Albulushi, et al.
Published: (2025-07-01)

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF
by: Zhen-Yu Yang, et al.
Published: (2025-08-01)

Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis
by: Mingzhi Lin, et al.
Published: (2025-05-01)

Comprehensive Analysis of the Effects of Sacubitril/Valsartan According to Sex Among Patients With Heart Failure and Reduced Ejection Fraction in PARADIGM‐HF
by: Misato Chimura, et al.
Published: (2025-05-01)

Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies
by: Wenwen Zheng, et al.
Published: (2025-08-01)

Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction
by: Junichi Ohno, et al.
Published: (2025-08-01)

Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics—insights from comprehensive CMR and serum biomarker analyses
by: Rebecca Elisabeth Beyer, et al.
Published: (2025-06-01)

Targeting atrial fibrillation in HFpEF: the emerging role of pulsed field ablation
by: A. S. Parwani, et al.
Published: (2025-07-01)

TO THE JUBILEE OF PROFESSOR STEPANOVA ELEONORA FEDOROVNA
by: D. V. Kompantsev, et al.
Published: (2018-07-01)

CHEMICAL COMPOSITION AND SALT LOAD IN RAINWATER OF MOSUL CITY-NINEVEH GOVERNORATE
by: Amer Abdul-Kareem, et al.
Published: (2018-03-01)

Efficacy of domestic anthelmintic drug mitranox and therapy dose titration against moniesiosis and nematodosis in sheep
by: S. A. Kozlov, et al.
Published: (2016-05-01)

Research and Design of Intelligent System for Operation in Locomotive Depot
by: Huawei LIU, et al.
Published: (2021-11-01)

Modulation of Gut Microbiota and Antibiotic Resistance Genes by Heat-Killed <i>Enterococcus faecalis</i> EF-2001 in High-Fat Diet-Induced Obesity Mice: A Shotgun Metagenomics Study
by: Ranjith Kumar Manoharan, et al.
Published: (2025-07-01)

Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K
by: Jeff C Liu, et al.
Published: (2014-10-01)

Polyphasic characterization and mating type allele distribution of Monilinia laxa in Iranian stone fruit orchards
by: Hadi Golmohammadi, et al.
Published: (2025-08-01)

A GIS-based methodology for hydropower potential assessment: balancing energy production and ecosystem sustainability
by: Arianna Paschetto, et al.
Published: (2025-09-01)

Exploration of a Postbiotic Derived from <i>Enterococcus faecium</i> HDRsEf1 and Its Probiotic Mechanisms
by: Yingying Chen, et al.
Published: (2025-06-01)

Proteinuria reduction by and safety of finerenone in Chinese patients with CKD without diabetes: a real-world retrospective study
by: Guangting Cong, et al.
Published: (2025-08-01)

Efficacy and safety of neoadjuvant treatment with chemotherapy and immune checkpoint blockades for potentially resectable gastric cancer: A retrospective study
by: Huiyun Wang, et al.
Published: (2025-12-01)

Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD
by: Mingxin Liu, et al.
Published: (2024-11-01)

Effect and Safety of Finerenone in Patients with IgA Nephropathy
by: Guo Y, et al.
Published: (2025-07-01)

How do psychosocial stress of the family, early-term birth and early childhood intervention affect the development of children's executive functions? Using Baileys scale III as a measurement for executive functions in children between 0 and 3 years
by: Minna R. K. Törmänen, et al.
Published: (2025-08-01)

Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board
by: M. V. Shestakova, et al.
Published: (2023-11-01)

VALUATION PROBLEMS OF THE PENSION SYSTEM EFFICIENCY
by: Yulia A. German
Published: (2016-08-01)